1. Gdynia G, Sauer SW, Kopitz J, Fuchs D, Duglova K, Ruppert T, et al. The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration. Nat Commun 2016;7:10764.
  2. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011;27:441-64.
  3. Yasuda M, Matsubara J, Yamasaki H, Fujita Y, Konishi H, Koinuma S, et al. Death-resistant and nonresistant malignant human cell lines under anoxia in vitro. Int J Clin Oncol 2007;12:455-62.
  4. Fidoamore A, Cristiano L, Antonosante A, d'Angelo M, Di Giacomo E, Astarita C, et al. Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance. Stem Cells Int 2016;2016:6809105.
  5. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-76.
  6. ElShamy WM, Sinha A, Said N. Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors? Stem Cells Int 2016;2016:4829106.
  7. Deynoux M, Sunter N, Herault O, Mazurier F. Hypoxia and Hypoxia-Inducible Factors in Leukemias. Front Oncol 2016;6:41.
  8. Monceaux V, Chiche-Lapierre C, Chaput C, Witko-Sarsat V, Prevost MC, Taylor CT, et al. Anoxia and glucose supplementation preserve neutrophil viability and function. Blood 2016;128:993-1002.
  9. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9.
  10. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008;452:230-3.
  11. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.
  12. Cerwenka A, Kopitz J, Schirmacher P, Roth W, Gdynia G. HMGB1: The metabolic weapon in the arsenal of NK cells. Mol Cell Oncol 2016;3:e1175538.
  13. Gdynia G. [HMGB1 as metabolic weapon in the arsenal of natural killer cells]. Pathologe 2016;37:169-72.
  14. Gdynia G, Heller A, Kopitz J, Schirmacher P, Dreger P, Sellner L. Metabolic testing of leukemia cells under anoxia for the identification of aggressive clinical CLL courses and resistance to chemo-immunotherapy.  101. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V.; 2017 May 19 2017; Erlangen; 2017. p. 61.